CVE-2026-42933: Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT se

criticalCVSS 10CVE-2026-42933

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

Details

Source: NVD Recent CVEs (US · database · site)
Severity: critical — CVSS 10
Published: 2026-07-23
Last updated: 2026-07-27
Exploitation: Not in CISA KEV at last sync

Original advisory: https://nvd.nist.gov/vuln/detail/CVE-2026-42933

Exploitation outlook

EPSS (FIRST.org) estimates each CVE’s probability of exploitation in the next 30 days — here is the CSIRTS.com read on those numbers.

Low exploitation riskCVE-2026-429330.29% 30-day exploitation probability — currently an unlikely target, but scores change as exploit code circulates. Riskier than 21% of all scored CVEs.

Referenced CVEs

CVE	CSIRTS overview	External
CVE-2026-42933	coverage & exploitation status	NVD · CVE.org

Same CVEs, other sources

How other CERTs, PSIRTs and databases cover the vulnerabilities in this advisory.

criticalPanduit IntraVUEcisa

Recent advisories for Pronetiqs IntraVUE

A cluster of recent advisories against the same product widens the attack surface — attackers routinely chain freshly published CVEs on one product, so review these together.

mediumCVE-2026-50044: Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerab…nvd · 2026-07-23
mediumCVE-2026-44955: Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system informatio…nvd · 2026-07-23
highCVE-2026-40430: Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerab…nvd · 2026-07-23
highCVE-2026-28698: Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system informatio…nvd · 2026-07-23